Site-specific drug carriers are required to exclusively deliver drug molecules to difficult targets within the body. They should do so in a form which protects the drug and host from one another. This contribution reviews the reasons for drug targeting, and describes some of the features required of two types of carrier system, i.e., particulates and soluble (bio)conjugates.
Get full access to this article
View all access options for this article.
References
1.
ArnonR.HurwitzE. (1983) Antibody- and polymer-drug conjugates, in Targeted drugs, (Edited by GoldbergE. P. (Wiley-Interscience, New York), pp. 23–56.
2.
BurgerJ. J.TomlinsonE.MulderE. M. A.McVieJ. G. (1985) Albumin microspheres for intraarterial tumour targeting. I. Pharmaceutical aspects, Int. J. Pharmaceutics, 23, 333–345.
3.
DavisS. S.IllumL.McVieJ. G.TomlinsonE. (1984) Microspheres and drug therapy. Pharmaceutical, immunological, and medical aspects (Elsevier, Amsterdam).
4.
GardnerC. R. (1985) Potential and limitations of drug targeting: An overview, Biomaterials, 6, 153–160.
5.
IllumL.DavisS. S. (1986) Private communication.
6.
IllumL.HunneyballI. M.DavisS. S. (1986) The effect of hydrophilic coatings on the uptake of colloidal particles by the liver and by peritoneal macrophages. Int. J. Pharmaceutics, 29, 53–66.
7.
KatoT. (1982). Encapsulated drugs in targeted cancer chemotherapy, in Controlled drug delivery, Volume II (CRC, Boca Raton), pp. 189–240.
8.
LindellB.AronsenK. F.RothmanU.SjoegrenH. O. (1977) The circulation in liver tissue and experimental liver metastases before and after embolism of the livery artery, Res. Expl. Med., 171, 63–70.
9.
MartodamR. R.TwumasiD. Y.LienerI. E.PowersJ. C.NishinoN.KrejcarekG. (1979) Albumin microspheres as a carrier of an inhibitor of leucocyte elastase: Potential therapeutic agent for emphysema, Proc. Natl. Acad. Sci., 5, 2128–2132.
10.
MizushimaY.WadaY.EtohY.WatanabeK. (1983) Anti-inflammatory effects of indomethacin ester incorporated in a lipid microsphere, J. Pharm. Pharmacol., 35, 398–399.
11.
PapahadjopoulosD. (1978) Liposomes and their uses in biology and medicine, Annal. New York Acad. Sci., Volume 308.
12.
PosteG.FidlerI. J. (1982) Therapeutic amplification of macrophage mediated destruction of tumor cells: An approach to cancer therapy that addresses the problem of tumor cell heterogeneity, in Design of models for testing cancer therapeutic agents, Edited by FidlerI. J.WhiteR. J. (Van Nostrand, New York), pp. 225–238.
13.
RowlandG. F. (1983) The use of antibodies and polymer conjugates in drug targeting and synergy, in Targeted drugs, Edited by GoldbergE. P. (Wiley-Interscience, New York), pp. 57–72.
14.
ThorpeP. E.MasonD. W.BrownA. N. F.SimmondsS. J.RossW. C. J.CumberA. J.ForresterJ. A. (1982) Selective killing of malignant cells in a leukaemic rat bone marrow using an antibody-ricin conjugate, Nature, 297, 594–596.
15.
TomlinsonE.BurgerJ. J.SchoonderwoerdE. M. A.KuikJ.SchlotzF. C.McVieJ. G.MillsS. (1982) Preparation and characterisation of albumin microspheres for intra-arterial tumour targeting of cytotoxic compounds, J. Pharm. Pharmacol. Suppl., 34, 88 P.
16.
TomlinsonE. (1983) Microsphere delivery systems for drug targeting and controlled release, Int. J. Pharm. Technol. Prod. Manuf., 4, 49–57.
17.
TomlinsonE.McVieJ. G. (1983) New directions in cancer chemotherapy. 2. Targeting with microspheres, Pharm. Int., 4, 281–284.
18.
TorchilinV. P. (1983) Immobilized enzymes and the use of immobilization principles for drug targeting, in Targeted drugs, Edited by GoldbergE. P. (Wiley-Interscience, New York), pp. 127–152.
19.
TrowbridgeI. S.DomingoD. L. (1982) Prospects for the clinical use of cytotoxic monoclonal antibody conjugates in the treatment of cancer, Cancer Surveys, 1, 543–556.
20.
VasileE.SimionescuM.SimionescuN. (1983) Visualization of the binding, endocytosis, and transcytosis of low-density lipoprotein in the arterial endothelium in situ, J. Cell Biol., 96, 1677–1689.
21.
WidderK. J.SenyeiA. E.RanneyD. F. (1979) Magnetically responsive microspheres and other carriers for the biophysical targeting of antitumour agents, Adv. Pharmacol. Chemotherapy, 16, 213–271.
22.
WillmottN.KamelH. M. H.CummingsJ.StuartJ. F. B.FlorenceA. T. (1984) Adriamycin-loaded albumin microspheres. Lung entrapment and fate in the rat, in Microspheres and drug therapy, Edited by DavisS. S.IllumL.McVieJ. G.TomlinsonE. (Elsevier, New York), pp. 205–216.
